Research prototype, not medical advice.

A 3-month course of rapamycin in middle-aged mice increases remaining life expectancy by up to 60%, with a lasting effect.

Confidence
Established
Level of evidence
Laboratory mammals
Observed in
Mouse
Mission
Map of aging (12 hallmarks)
Concepts
Deregulated nutrient sensingRapamycin (and analogues: everolimus)

What the sources say

Each row is an article. “Supports”: it backs the claim. “Contradicts”: it goes against it. “Qualifies”: it limits it (another species, a weaker effect…).

DirectionSourceWhere in the articleStatus
Supports Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice
Bitto et al. · eLife 2016
— Verified

Related claims